These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 25918550)

  • 1. Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson's disease: a systematic review and meta-analysis.
    Wang J; Xue L; Jiang J; Liu F; Wu P; Lu J; Zhang H; Bao W; Xu Q; Ju Z; Chen L; Jiao F; Lin H; Ge J; Zuo C; Tian M
    NPJ Digit Med; 2024 Jan; 7(1):17. PubMed ID: 38253738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease.
    Barbero JA; Unadkat P; Choi YY; Eidelberg D
    Neurotherapeutics; 2023 Oct; 20(6):1653-1668. PubMed ID: 37684533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian Optimization with Support Vector Machine Model for Parkinson Disease Classification.
    Elshewey AM; Shams MY; El-Rashidy N; Elhady AM; Shohieb SM; Tarek Z
    Sensors (Basel); 2023 Feb; 23(4):. PubMed ID: 36850682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational molecular imaging and drug development in Parkinson's disease.
    Haider A; Elghazawy NH; Dawoud A; Gebhard C; Wichmann T; Sippl W; Hoener M; Arenas E; Liang SH
    Mol Neurodegener; 2023 Feb; 18(1):11. PubMed ID: 36759912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional brain networks in the evaluation of patients with neurodegenerative disorders.
    Perovnik M; Rus T; Schindlbeck KA; Eidelberg D
    Nat Rev Neurol; 2023 Feb; 19(2):73-90. PubMed ID: 36539533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment.
    Jiang J; Sheng C; Chen G; Liu C; Jin S; Li L; Jiang X; Han Y;
    Geroscience; 2022 Aug; 44(4):2319-2336. PubMed ID: 35581512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Diagnostic Reasoning Method for Benign Paroxysmal Positional Vertigo Based on Dynamic Uncertain Causality Graph.
    Dong C; Wang Y; Zhou J; Zhang Q; Wang N
    Comput Math Methods Med; 2020; 2020():1541989. PubMed ID: 32411277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts.
    Meles SK; Renken RJ; Pagani M; Teune LK; Arnaldi D; Morbelli S; Nobili F; van Laar T; Obeso JA; Rodríguez-Oroz MC; Leenders KL
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):437-450. PubMed ID: 31768600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.
    Krismer F; Seppi K; Göbel G; Steiger R; Zucal I; Boesch S; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Mov Disord; 2019 Jul; 34(7):1041-1048. PubMed ID: 30919495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes.
    Devrome M; Van Weehaeghe D; De Vocht J; Van Damme P; Van Laere K; Koole M
    EJNMMI Res; 2018 Dec; 8(1):110. PubMed ID: 30547248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.
    Matthews DC; Lerman H; Lukic A; Andrews RD; Mirelman A; Wernick MN; Giladi N; Strother SC; Evans KC; Cedarbaum JM; Even-Sapir E
    Neuroimage Clin; 2018; 20():572-579. PubMed ID: 30186761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.
    Walker Z; Gandolfo F; Orini S; Garibotto V; Agosta F; Arbizu J; Bouwman F; Drzezga A; Nestor P; Boccardi M; Altomare D; Festari C; Nobili F;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1534-1545. PubMed ID: 29779045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
    Whitwell JL; Höglinger GU; Antonini A; Bordelon Y; Boxer AL; Colosimo C; van Eimeren T; Golbe LI; Kassubek J; Kurz C; Litvan I; Pantelyat A; Rabinovici G; Respondek G; Rominger A; Rowe JB; Stamelou M; Josephs KA;
    Mov Disord; 2017 Jul; 32(7):955-971. PubMed ID: 28500751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing Parkinson's disease from atypical parkinsonian syndromes using PET data and a computer system based on support vector machines and Bayesian networks.
    Segovia F; Illán IA; Górriz JM; Ramírez J; Rominger A; Levin J
    Front Comput Neurosci; 2015; 9():137. PubMed ID: 26594165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of Parkinsonian syndromes from FDG-PET brain data using decision trees with SSM/PCA features.
    Mudali D; Teune LK; Renken RJ; Leenders KL; Roerdink JB
    Comput Math Methods Med; 2015; 2015():136921. PubMed ID: 25918550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features.
    Spetsieris PG; Ma Y; Dhawan V; Eidelberg D
    Neuroimage; 2009 May; 45(4):1241-52. PubMed ID: 19349238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
    Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
    Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data.
    Manzanera OM; Meles SK; Leenders KL; Renken RJ; Pagani M; Arnaldi D; Nobili F; Obeso J; Oroz MR; Morbelli S; Maurits NM
    Int J Neural Syst; 2019 Nov; 29(9):1950010. PubMed ID: 31046514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y; Kato T; Tadokoro M; Sobue G
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.